Review



cytoscan hd/oncoscan array  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher cytoscan hd/oncoscan array
    Cytoscan Hd/Oncoscan Array, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/cytoscan+hd+array/pmc11798607-147-0-3
    Average 90 stars, based on 1 article reviews
    cytoscan hd/oncoscan array - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Integrated cytogenetic and genomic profiling of the MDS-L cell line.
    Article Snippet: MDS-L DNA was also analyzed with the ThermoFisher® CytoScan 750 K microarray for the identification of both CNA and ROH.

    Article Title: Integrated cytogenetic and genomic profiling of the MDS-L cell line
    Article Snippet: MDS-L DNA was also analyzed with the ThermoFisher ® CytoScan 750 K microarray for the identification of both CNA and ROH.

    Microarray:

    Article Title: Duplication of chromosome 1q32.1q44: presented with ventriculomegaly and transient myeloproliferative disorder of the newborn
    Article Snippet: .. Chromosomal microarray testing was performed using the Affymetrix Cytoscan HD Microarray assay (ThermoFisher Scientific). ..

    Article Title: Distinct chromosome abnormality patterns for differential diagnosis of hepatocellular carcinoma and cholangiocarcinoma.
    Article Snippet: The DNA was eluted with buffer in a microcentrifuge tube and centrifuged for 1 minute at 6000 g. DNA concentration was measured using a NanoDrop spectrophotometer, and all genomic DNA samples were stored at -20 °C for future use. .. Chromosome microarray analysis was conducted using the CytoScanTM 750K platform (Thermo Fisher Scientific, Waltham, MA, USA). ..

    Article Title: Artifacts, Not Differences in Sex Development, Are the Predominant Cause of Phenotypic Sex Discordance With Prenatal Cell-Free DNA Screening: A Review of 33 Cases.
    Article Snippet: Objective: Although fetal sex chromosome complement prediction by prenatal cell‐free DNA (cfDNA) screening is highly accurate, discordance between the cfDNA‐inferred chromosomal sex and phenotypic sex observed via ultrasonography or at birth, that is, “fetal sex discordance”, does rarely occur.. Such discordance may be caused by differences in sex development (DSD) or technical or biological artifacts.. This study aims to provide insights into the proportion of fetal sex discordance cases caused by DSD versus non‐DSD artifacts.

    Software:

    Article Title: Artifacts, Not Differences in Sex Development, Are the Predominant Cause of Phenotypic Sex Discordance With Prenatal Cell-Free DNA Screening: A Review of 33 Cases.
    Article Snippet: Objective: Although fetal sex chromosome complement prediction by prenatal cell‐free DNA (cfDNA) screening is highly accurate, discordance between the cfDNA‐inferred chromosomal sex and phenotypic sex observed via ultrasonography or at birth, that is, “fetal sex discordance”, does rarely occur.. Such discordance may be caused by differences in sex development (DSD) or technical or biological artifacts.. This study aims to provide insights into the proportion of fetal sex discordance cases caused by DSD versus non‐DSD artifacts.



    Similar Products

    90
    Fisher Scientific comparative genomic hybridization array cgha oncoscan ffpe assays kits
    Comparative Genomic Hybridization Array Cgha Oncoscan Ffpe Assays Kits, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/comparative+genomic+hybridization+array+cgha+oncoscan+ffpe+assays+kits/pm40506517-84-6-19
    Average 90 stars, based on 1 article reviews
    comparative genomic hybridization array cgha oncoscan ffpe assays kits - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher cytoscan hd/oncoscan array
    Cytoscan Hd/Oncoscan Array, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/cytoscan+hd+array/pmc11798607-147-0-3
    Average 90 stars, based on 1 article reviews
    cytoscan hd/oncoscan array - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher oncoscan snp array
    Oncoscan Snp Array, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/10__5858_slash_arpa__2024___0267___oa-58-6-22
    Average 90 stars, based on 1 article reviews
    oncoscan snp array - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher oncoscan cna arrays
    OSCHP plots by Affymetrix <t>OncoScan</t> for whole‐genome <t>CNA.</t> (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.
    Oncoscan Cna Arrays, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/pmc11717496-99-4-8
    Average 90 stars, based on 1 article reviews
    oncoscan cna arrays - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher oncoscan cnv plus array
    OSCHP plots by Affymetrix <t>OncoScan</t> for whole‐genome <t>CNA.</t> (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.
    Oncoscan Cnv Plus Array, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/oncoscan+ffpe+assay+kit/pm39692003-39-14-18
    Average 90 stars, based on 1 article reviews
    oncoscan cnv plus array - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher oncoscan cnv plus arrays
    OSCHP plots by Affymetrix <t>OncoScan</t> for whole‐genome <t>CNA.</t> (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.
    Oncoscan Cnv Plus Arrays, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/oncoscan+ffpe+assay+kit/pm39554783-47-10-14
    Average 90 stars, based on 1 article reviews
    oncoscan cnv plus arrays - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher inversion probe array oncoscan copy number variation assay
    OSCHP plots by Affymetrix <t>OncoScan</t> for whole‐genome <t>CNA.</t> (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.
    Inversion Probe Array Oncoscan Copy Number Variation Assay, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/inversion+probe+array+oncoscan+copy+number+variation+assay/pmc11576554-31-10-19
    Average 90 stars, based on 1 article reviews
    inversion probe array oncoscan copy number variation assay - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher oncoscan array data (oschp les
    OSCHP plots by Affymetrix <t>OncoScan</t> for whole‐genome <t>CNA.</t> (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.
    Oncoscan Array Data (Oschp Les, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/ppr0926610-113-18-33
    Average 90 stars, based on 1 article reviews
    oncoscan array data (oschp les - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher oncoscan® ffpe snp-array kit
    OSCHP plots by Affymetrix <t>OncoScan</t> for whole‐genome <t>CNA.</t> (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.
    Oncoscan® Ffpe Snp Array Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/oncoscan+array/pm39215000-353-6-11
    Average 90 stars, based on 1 article reviews
    oncoscan® ffpe snp-array kit - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    OSCHP plots by Affymetrix OncoScan for whole‐genome CNA. (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.

    Journal: The Journal of Pathology

    Article Title: Genomic characterization and histologic analysis of uterine leiomyosarcoma arising from leiomyoma with bizarre nuclei

    doi: 10.1002/path.6379

    Figure Lengend Snippet: OSCHP plots by Affymetrix OncoScan for whole‐genome CNA. (A) Genomic copy number gain and loss for chromosomes 1 to 22 and X were obtained in nine cases, with LM‐BN regions presented above and LMS regions below. Arrows indicate CNA shared by LM‐BN and LMS, indicating clonality. (Case 1 LM‐BN was tetraploid. A circular dot in case 2 indicates STUMP component.) (B, C) Dot plots represented the number of detectable sites of (B) CNA gain and (C) loss in genomic regions from nine cases. (D) Dot plots for LOH in LM‐BN and LMS. (E, F) Fraction of genome alteration in LMS and LM‐BN regions (E) individually and (F) combined analysis of fraction of genome alteration in LMS and LM‐BN. * p <0.05; ** p <0.01; *** p < 0.001; ns = no statistical significance.

    Article Snippet: DNA was analyzed using Affymetrix OncoScan CNA arrays (Thermo Fisher Scientific, Santa Clara, CA, USA).

    Techniques: